A detailed history of Kinnevik Ab (Publ) transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Kinnevik Ab (Publ) holds 11,905,668 shares of RXRX stock, worth $73.6 Million. This represents 100.0% of its overall portfolio holdings.

Number of Shares
11,905,668
Previous 11,905,668 -0.0%
Holding current value
$73.6 Million
Previous $89.3 Million 12.13%
% of portfolio
100.0%
Previous 100.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 08, 2024

BUY
$7.35 - $10.05 $11 Million - $15.1 Million
1,500,000 Added 14.42%
11,905,668 $89.3 Million
Q2 2023

Jul 25, 2023

BUY
$4.56 - $9.94 $12.6 Million - $27.4 Million
2,752,607 Added 35.97%
10,405,668 $77.7 Million
Q4 2022

Feb 01, 2023

BUY
$7.16 - $12.7 $54.8 Million - $97.2 Million
7,653,061 New
7,653,061 $59 Million

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.12B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Kinnevik Ab (Publ) Portfolio

Follow Kinnevik Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kinnevik Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Kinnevik Ab (Publ) with notifications on news.